Nova Scotia

BioPharma

Canadian province puts $5M to work toward better cancer vaccines via Immunovaccine

The Province of Nova Scotia is lending $5 million to clinical-stage biotech Immunovaccine, which is developing an adjuvant platform that could make cancer vaccines more effective more quickly. The technology, aptly named DepoVax, creates a “depot” at the site of injection, attracting the immune system’s antigen-presenting cells to take up the vaccine. It’s used with […]